跳到正文
原文
NEJM· @NEJM · X·· 4 天前AI 评分28
AI 导读

在一项观察性研究中,胸腺瘤相关免疫失调的特征为干扰素-γ通路激活。四名重症患者接受Janus激酶1/2抑制剂治疗后,出现临床和生物标志物应答。完整研究结果:https://nej.md/3UuLcil

正文

In an observational study, thymoma-associated immune dysregulation was characterized by interferon-γ pathway activation. Four patients with severe disease treated with Janus kinase 1/2 inhibitors had clinical and biomarker responses. Full study results: https://nej.md/3UuLcil

来源:NEJM · x.com